Location of Repository

What to do about poor clinical performance in clinical trials

By S. Mason, J. Nicholl and R. Lilford


The performance of individual clinicians is being monitored as never before. Su Mason and colleagues discuss the implications of this for clinical trials and recommend what should happen if during a trial the performance of one clinician or one centre is identified as being particularly poor. Tom Treasure, a surgeon, wants the monitoring to be done fairly and to take account of the complexities of clinical practice; and Heather Goodare, a patient, wants to be told when things go wrong.\ud \ud The Department of Health in England has issued guidelines for research governance stating that healthcare organisations remain responsible for the quality of all aspects of patients' care whether or not some aspects of the care are part of a research study.1 We discuss how this obligation can be met in multicentre trials, given that data on the performance of clinicians are held by the trial management team, not by the host organisation

Publisher: BMJ Publishing
Year: 2002
OAI identifier: oai:eprints.whiterose.ac.uk:4910

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.